全文获取类型
收费全文 | 39297篇 |
免费 | 3259篇 |
国内免费 | 162篇 |
专业分类
耳鼻咽喉 | 597篇 |
儿科学 | 933篇 |
妇产科学 | 755篇 |
基础医学 | 4973篇 |
口腔科学 | 937篇 |
临床医学 | 3666篇 |
内科学 | 8788篇 |
皮肤病学 | 420篇 |
神经病学 | 3452篇 |
特种医学 | 1306篇 |
外科学 | 6370篇 |
综合类 | 832篇 |
一般理论 | 28篇 |
预防医学 | 3284篇 |
眼科学 | 1078篇 |
药学 | 2607篇 |
中国医学 | 90篇 |
肿瘤学 | 2602篇 |
出版年
2022年 | 224篇 |
2021年 | 665篇 |
2020年 | 374篇 |
2019年 | 661篇 |
2018年 | 763篇 |
2017年 | 617篇 |
2016年 | 606篇 |
2015年 | 673篇 |
2014年 | 1110篇 |
2013年 | 1614篇 |
2012年 | 2406篇 |
2011年 | 2467篇 |
2010年 | 1379篇 |
2009年 | 1313篇 |
2008年 | 2257篇 |
2007年 | 2412篇 |
2006年 | 2591篇 |
2005年 | 2583篇 |
2004年 | 2447篇 |
2003年 | 2462篇 |
2002年 | 2287篇 |
2001年 | 556篇 |
2000年 | 553篇 |
1999年 | 591篇 |
1998年 | 570篇 |
1997年 | 446篇 |
1996年 | 407篇 |
1995年 | 350篇 |
1994年 | 332篇 |
1993年 | 296篇 |
1992年 | 408篇 |
1991年 | 392篇 |
1990年 | 363篇 |
1989年 | 325篇 |
1988年 | 316篇 |
1987年 | 290篇 |
1986年 | 295篇 |
1985年 | 263篇 |
1984年 | 292篇 |
1983年 | 243篇 |
1982年 | 271篇 |
1981年 | 252篇 |
1980年 | 220篇 |
1979年 | 200篇 |
1978年 | 215篇 |
1977年 | 198篇 |
1976年 | 157篇 |
1974年 | 177篇 |
1973年 | 165篇 |
1972年 | 143篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
51.
The thyroid surgeon must have a full understanding of the anatomy and surgical approaches to the mediastinum. Although most benign substernal goiters may be removed by a transcervical approach, the surgeon needs to know indications for transclavicular and median sternotomy approaches. When there is direct evidence of extension of thyroid cancer into the mediastinum, the possibility of median sternotomy should be considered. This is certainly mandated when disease extends to the inferior mediastinum. Superior mediastinal node dissection is usually easy to approach transcervically. Unilateral extension of the disease may be accessed readily with a transclavicular approach for most cases. Careful dissection of the recurrent laryngeal nerve as well as parathyroids is essential to diminish postoperative morbidity. The morbidity is a reflection of the experience and technical skills of the surgeon as well as the extent of the disease. The best results for resection of substernal thyroid disease are obtained by the experienced thyroid surgeon, not the occasional operator. 相似文献
52.
Marjan Boerma Gregory R Burton Junru Wang Louis M Fink Robert E McGehee Martin Hauer-Jensen 《Blood coagulation & fibrinolysis》2006,17(3):173-180
Immortalized cell lines offer significant logistical advantages over primary cells when used for in-vitro studies. Immortalized cells may, however, exhibit important differences relative to their primary cell counterparts. In this study, microarrays were used to make a genome-wide comparison between primary human umbilical vein endothelial cells (HUVECs) and EA.hy926, an immortalized HUVEC cell line, in their baseline properties and in their response to inhibition of the mevalonate pathway with an inhibitor of hydroxy methylglutaryl-coenzyme A reductase (statin). HUVECs and EA.hy926 were incubated with control medium, atorvastatin, mevalonate, or a combination of atorvastatin and mevalonate for 24 h. Gene expression profiles were obtained in duplicates using Affymetrix Human Genome U133A 2.0 arrays (Santa Clara, California, USA). Probe-sets were selected according to the following criteria: a twofold or greater increase/decrease in atorvastatin-treated cells compared with untreated cells; a twofold or greater reversal of the effect of atorvastatin by combined treatment with atorvastatin and mevalonate; no significant change in gene expression in cells treated with mevalonate alone compared with untreated cells. Most genes that were expressed by untreated HUVECs, were also expressed by untreated EA.hy926 cells. EA.hy926 cells, however, constitutively expressed a large number of additional genes, many of which were related to cell cycle control and apoptosis. Atorvastatin induced differential expression (> or = twofold) of 103 genes in HUVECs (10 up, 93 down) and 466 genes in EA.hy926 cells (198 up, 268 down). Applying the above selection criteria, thrombomodulin and tissue plasminogen activator were up-regulated in both cell types, whereas, connective tissue growth factor, thrombospondin-1, and cysteine-rich angiogenic inducer 61 were down-regulated. In conclusion, EA.hy926 cells retain most of the characteristics of endothelial cells under baseline conditions as well as after treatment with atorvastatin. It is necessary, however, to carefully select and validate changes in genes that are the focus of studies when using EA.hy926 cells. While this cell line is highly useful in studies on some genes, including genes encoding molecules involved in regulating thrombohemorrhagic homeostasis, they appear to be less suited for studies focused on other genes, particularly those involved in the regulation of cell proliferation and apoptosis. 相似文献
53.
Daniel B. Costa Christopher A. Fisher Kenneth B. Miller German A. Pihan David P. Steensma Richard J. Gibbons Douglas R. Higgs 《European journal of haematology》2006,76(5):432-435
Abstract: We describe a patient with acquired alpha-thalassemia myelodysplastic syndrome (ATMDS). A previously healthy 66-year-old man presented with hemoglobin of 9.3 g/dL, mean corpuscular volume 59 fL, and a bone marrow aspirate with increased erythroid precursors and hypolobulated megakaryocytes. Hemoglobin H inclusions were seen in most red cells after 1% brilliant cresyl blue supravital stain of the peripheral blood. At the molecular level, we identified of a novel mutation in the most 3' exon of the ATRX gene ( C GA→ T GA substitution in codon 2407) resulting in a premature termination codon (p.R2407X). This case provides further evidence for a link between ATRX mutations and ATMDS, and suggests a possible role for the conserved Q-box element in ATRX function. 相似文献
54.
Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf® ) in the treatment of lower-extremity ulcers 总被引:1,自引:0,他引:1
Joseph Cavorsi MD FACS ; Frank Vicari MD FACS FAAP ; Douglas J. Wirthlin MD FACS ; William Ennis DO MBA FACOS ; Robert Kirsner MD ; Sean M. O''Connell PhD ; John Steinberg DPM ; Vincent Falanga MD 《Wound repair and regeneration》2006,14(2):102-109
Tissue-engineered skin substitutes such as Apligraf have emerged over the past 20 years as among the most carefully studied and efficacious of the advanced wound modalities. These products have been proven as effective enhancements to general wound care, promoting wound closure particularly in instances where conventional wound care fails. Marketed for hard-to-heal wounds since 1998, Apligraf has become part of standard wound care in many wound centers across the United States. Despite this situation, few general wound care guidelines incorporate advanced and active wound-healing technologies, such as tissue-engineered skin products. Because of this deficiency, appropriate patient selection and proper use of these product remain largely unaddressed within the general wound care community. Here, we describe the development of guidelines surrounding optimal use of the bilayered living cell therapy, Apligraf, in the treatment of the two types of lower extremity ulcers for which the product is FDA approved: venous leg ulcer and diabetic foot ulcer. The guidelines detailed in this article focus on the identification and selection of patients who are at risk for failure of standard wound care therapy and thus appropriate for Apligraf treatment. The intended audience for these guidelines is the general wound care practitioner, for whom the developed treatment algorithms and accompanying figure legends should provide practical, user-friendly direction simplifying both patient selection and appropriate use of Apligraf within the context of good wound-healing practice. 相似文献
55.
Estrogen receptor beta polymorphisms are associated with bone mass in women and men: the Framingham Study. 总被引:5,自引:0,他引:5
Amanda M Shearman David Karasik Kristen M Gruenthal Serkalem Demissie L Adrienne Cupples David E Housman Douglas P Kiel 《Journal of bone and mineral research》2004,19(5):773-781
ESR2 is expressed in bone cells, yet few studies have tested its variation for association with BMD, an important determinant of osteoporotic fractures. This was investigated in 723 men and 795 women from the Framingham study. Results show association of variation in this gene with BMD in both women and men. INTRODUCTION: Osteoporotic fracture risk is highly dependent on bone density, a quantitative multifactorial trait with a substantial genetic component. In contrast to the growing body of evidence that estrogen receptor alpha (ESR1) plays a role in bone metabolism, few studies have examined the estrogen receptor beta (ESR2) gene for association with BMD. An ESR2 CA repeat polymorphism, D14S1026, was associated with BMD in two small studies, each with <200 women. MATERIALS AND METHODS: The objective of this investigation was to assess whether D14S1026 or four other intronic polymorphisms were associated with BMD in 723 men and 795 women (mean age, 60 years) from the offspring cohort of the population-based Framingham Study. BMD was measured at the femur (neck, trochanter, and Ward's area) and the lumbar spine (L(2)-L(4)). RESULTS: In both women and men, there was significant association of D14S1026 genotype with measures of femoral but not spinal BMD. In addition, genotypes of two common single nucleotide polymorphisms, rs1256031 and rs1256059, in strong linkage disequilibrium with one another but not with D14S1026, were associated with measures of femoral BMD in men. The rs1256031 genotypes had up to a 4.0% difference in mean femoral BMD. An inferred rs1256031-D14S1026-rs1256059 haplotype C-23CA-T was significantly associated with reduced femoral BMD in women (p = 0.03, 0.003, and 0.01 for neck, trochanter, and Ward's area, respectively). Haplotype-based BMD differences ranged from 3.0% to 4.3%. CONCLUSIONS: We have observed significant association of common ESR2 variants with measures of femoral BMD in both men and women. 相似文献
56.
57.
58.
59.
John S. Witte Giske Ursin Jack Siemiatycki W. Douglas Thompson Annali Paganini-Hill Robert W. Haile 《Breast cancer research and treatment》1997,42(3):243-251
We investigated associations between diet and premenopausal bilateral breast cancer in a familial matched case-control study. We studied 140 cases from population-based registries in Los Angeles County (California) and Connecticut, and from the major hospitals in the southern parts of the Province of Quebec. Unaffected sisters of the cases served as matched controls (222 total). Dietary intake were assessed with a food frequency questionnaire. Total fat, monounsaturated fat, polyunsaturated fat, oleic acid, and linoleic acid intake was inversely associated with premenopausal bilateral breast cancer risk. Consumption of carbohydrates (and sweetened beverages) was associated with an increased risk. We observed no associations for dietary fiber, antioxidants, or major food groupings, but we did observe inverse associations for intake of low fat dairy products and tofu. These findings suggest that monounsaturated and polyunsaturated fats, as well as soy foods, might reduce the risk of premenopausal bilateral breast cancer. 相似文献
60.